Lyssikatos Joseph P
Officer at ELVN
- Sold, on record
- $11.8M
- Dollars the filings state
- Form 4 sales
- 36
- Latest Feb 6, 2026
- Form 144 notices
- 26
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ELVNEnliven Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ELVNNoticeJan 8, 2026 2026
Filed to sell 82,500 shares ($1.3M)
Lyssikatos Joseph P, Officer
10b5-1 plan6.9x usual sizeFiling
- 2 Form 144 notice ELVNNoticeJan 9, 2026 +1 day
Filed to sell 75,000 shares ($1.7M)
Lyssikatos Joseph P, Officer
10b5-1 plan6.3x usual sizeFiling
- 3 Form 4 sale ELVNUnusualJan 9, 2026 same day
Sold 132,500 shares at $26.23 ($3.5M)
Lyssikatos Joseph P, CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 14.8% of holdings ($23.5M position)765,188 shares left11x usual sizeFollows a Form 144Filing
- 4 Form 4 sale ELVNRoutineJan 20, 2026 +11 days
Sold 20,000 shares at $26.75 ($535k)
Lyssikatos Joseph P, CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 2.6% of holdings ($20.5M position)745,188 shares left1.7x usual sizeFollows a Form 144Filing
- 5 Form 4 sale ELVNRoutineFeb 6, 2026 +17 days
Sold 5,000 shares at $29.04 ($145k)
Lyssikatos Joseph P, CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 0.7% of holdings ($21.6M position)740,188 shares left0.4x usual sizeFollows a Form 144Filing
- 6 Form 144 notice ELVNNoticeFeb 18, 2026 +12 days
Filed to sell 75,000 shares ($2M)
Lyssikatos Joseph P, Officer
10b5-1 plan6.3x usual sizeFiling
- 7 Form 144 notice ELVNNoticeMar 31, 2026 +41 days
Filed to sell 25,000 shares ($915k)
Lyssikatos Joseph P, Officer
10b5-1 plan2.1x usual sizeFiling
- 8 Form 144 notice ELVNNoticeApr 30, 2026 +30 days
Filed to sell 25,000 shares ($1.1M)
Lyssikatos Joseph P, Officer
10b5-1 plan2.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (62)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Apr 30, 2026 | ELVN | Officer | Form 144 notice | 25,000 | $1.1M | Notice | SEC | |
| Mar 31, 2026 | Mar 31, 2026 | ELVN | Officer | Form 144 notice | 25,000 | $915k | Notice | SEC | |
| Feb 18, 2026 | Feb 18, 2026 | ELVN | Officer | Form 144 notice | 75,000 | $2M | Notice | SEC | |
| Feb 6, 2026 | Feb 10, 2026 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,000 | $145k | 0.7% | Routine | SEC |
| Jan 20, 2026 | Jan 22, 2026 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 20,000 | $535k | 2.6% | Routine | SEC |
| Jan 9, 2026 | Jan 12, 2026 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 132,500 | $3.5M | 14.8% | Unusual | SEC |
| Jan 9, 2026 | Jan 9, 2026 | ELVN | Officer | Form 144 notice | 75,000 | $1.7M | Notice | SEC | |
| Jan 8, 2026 | Jan 8, 2026 | ELVN | Officer | Form 144 notice | 82,500 | $1.3M | Notice | SEC | |
| Dec 19, 2025 | Dec 23, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,000 | $84k | 0.6% | Routine | SEC |
| Dec 19, 2025 | Dec 19, 2025 | ELVN | Officer | Form 144 notice | 5,000 | $83k | Notice | SEC | |
| Nov 19, 2025 | Nov 21, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,500 | $279k | 1.4% | Routine | SEC |
| Nov 19, 2025 | Nov 19, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $282k | Notice | SEC | |
| Oct 20, 2025 | Oct 22, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,500 | $276k | 1.3% | Routine | SEC |
| Oct 20, 2025 | Oct 20, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $268k | Notice | SEC | |
| Sep 26, 2025 | Sep 30, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 4,000 | $81k | 0.4% | Routine | SEC |
| Sep 23, 2025 | Sep 25, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 1,500 | $30k | 0.2% | Routine | SEC |
| Sep 19, 2025 | Sep 23, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 7,000 | $136k | 0.7% | Routine | SEC |
| Sep 19, 2025 | Sep 19, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $249k | Notice | SEC | |
| Aug 21, 2025 | Aug 21, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,500 | $248k | 1.3% | Routine | SEC |
| Aug 19, 2025 | Aug 19, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $247k | Notice | SEC | |
| Jul 21, 2025 | Jul 23, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,500 | $279k | 1.3% | Routine | SEC |
| Jul 21, 2025 | Jul 21, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $283k | Notice | SEC | |
| Jun 20, 2025 | Jun 24, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,500 | $268k | 1.3% | Routine | SEC |
| Jun 20, 2025 | Jun 20, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $270k | Notice | SEC | |
| Jun 3, 2025 | Jun 5, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 7,500 | $150k | 0.8% | Routine | SEC |
| Jun 3, 2025 | Jun 3, 2025 | ELVN | Officer | Form 144 notice | 7,500 | $144k | Notice | SEC | |
| May 19, 2025 | May 21, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,000 | $82k | 0.5% | Routine | SEC |
| May 19, 2025 | May 19, 2025 | ELVN | Officer | Form 144 notice | 5,000 | $84k | Notice | SEC | |
| May 2, 2025 | May 5, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 7,500 | $150k | 0.8% | Routine | SEC |
| May 1, 2025 | May 1, 2025 | ELVN | Officer | Form 144 notice | 7,500 | $142k | Notice | SEC | |
| Apr 21, 2025 | Apr 23, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,000 | $80k | 0.5% | Routine | SEC |
| Apr 21, 2025 | Apr 21, 2025 | ELVN | Officer | Form 144 notice | 5,000 | $83k | Notice | SEC | |
| Mar 19, 2025 | Mar 21, 2025 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,500 | $258k | 1.2% | Routine | SEC |
| Mar 19, 2025 | Mar 19, 2025 | ELVN | Officer | Form 144 notice | 12,500 | $254k | Notice | SEC | |
| Oct 18, 2024 | Oct 22, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 847 | $25k | 0.1% | Routine | SEC |
| Oct 18, 2024 | Oct 18, 2024 | ELVN | Officer | Form 144 notice | 65,000 | $1.8M | Notice | SEC | |
| Oct 9, 2024 | Oct 10, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 51,145 | $1.4M | 4.8% | Unusual | SEC |
| Oct 9, 2024 | Oct 9, 2024 | ELVN | Officer | Form 144 notice | 12,000 | $336k | Notice | SEC | |
| Oct 7, 2024 | Oct 8, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 10,229 | $282k | 0.9% | Routine | SEC |
| Oct 1, 2024 | Oct 3, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 527 | $15k | 0.0% | Routine | SEC |
| Aug 29, 2024 | Sep 3, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $270k | 1.1% | Routine | SEC |
| Jul 31, 2024 | Aug 2, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 3,099 | $85k | 0.3% | Routine | SEC |
| Jul 31, 2024 | Jul 31, 2024 | ELVN | Officer | Form 144 notice | 65,000 | $1.7M | Notice | SEC | |
| Jul 29, 2024 | Jul 31, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $320k | 1.1% | Routine | SEC |
| Jul 29, 2024 | Jul 29, 2024 | ELVN | Officer | Form 144 notice | 12,000 | $328k | Notice | SEC | |
| Jul 1, 2024 | Jul 3, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $275k | 1.1% | Routine | SEC |
| Jul 1, 2024 | Jul 1, 2024 | ELVN | Officer | Form 144 notice | 12,000 | $280k | Notice | SEC | |
| May 29, 2024 | May 31, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $261k | 100.0% | Routine | SEC |
| May 29, 2024 | May 29, 2024 | ELVN | Officer | Form 144 notice | 12,000 | $279k | Notice | SEC | |
| Apr 29, 2024 | May 1, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $215k | 100.0% | Routine | SEC |
| Apr 11, 2024 | Apr 15, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 30,000 | $751k | 100.0% | Routine | SEC |
| Apr 11, 2024 | Apr 11, 2024 | ELVN | Officer | Form 144 notice | 42,000 | $832k | Notice | SEC | |
| Apr 1, 2024 | Apr 3, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $223k | 100.0% | Routine | SEC |
| Feb 29, 2024 | Mar 4, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $197k | 100.0% | Routine | SEC |
| Jan 29, 2024 | Jan 31, 2024 | ELVN | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 12,000 | $190k | 100.0% | Routine | SEC |
| Jan 29, 2024 | Jan 29, 2024 | ELVN | Officer | Form 144 notice | 36,000 | $575k | Notice | SEC | |
| Dec 29, 2023 | Jan 3, 2024 | ELVN | Chief Scientific Officer | Form 4 sale | 12,000 | $171k | 100.0% | Routine | SEC |
| Dec 22, 2023 | Dec 26, 2023 | ELVN | Chief Scientific Officer | Form 4 sale | 6,566 | $86k | 100.0% | Routine | SEC |
| Dec 20, 2023 | Dec 21, 2023 | ELVN | Chief Scientific Officer | Form 4 sale | 8,888 | $116k | 100.0% | Routine | SEC |
| Nov 3, 2023 | Nov 6, 2023 | ELVN | Chief Scientific Officer | Form 4 sale | 8,546 | $112k | 100.0% | Routine | SEC |
| Sep 29, 2023 | Oct 3, 2023 | ELVN | Chief Scientific Officer | Form 4 sale | 12,000 | $163k | 100.0% | Routine | SEC |
| Sep 29, 2023 | Sep 29, 2023 | ELVN | Officer | Form 144 notice | 36,000 | $495k | Notice | SEC |